[{"NetIncomeLossConverted_1_Q2_USD":60600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":137500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":137300000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.23,"CommonStockSharesConverted_0_Q2_shares":136500000.0,"Assets_0_Q2_USD":12128300000.0,"RevenuesConverted_2_Q2_USD":2560100000.0,"RevenuesConverted_1_Q2_USD":1219100000.0,"StockholdersEquity_0_Q2_USD":5910400000.0,"EarningsPerShareDiluted_2_Q2_USD":1.22,"EarningsPerShareDiluted_1_Q2_USD":0.44,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":462700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":136400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":136300000.0,"StockholdersEquityConverted_0_Q2_USD":5910900000.0,"NetIncomeLossConverted_2_Q2_USD":167000000.0,"EarningsPerShareBasic_1_Q2_USD":0.44,"EarningsPerShareBasic_2_Q2_USD":1.23,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200805"}]